Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

84.68% of the stock is owned by institutional investors and hedge funds. 10x Genomics, Inc, a life science technology company, develops and sells instruments, consumables, and software for ...

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cathie Wood's ARK ETFs have disclosed their daily trades for Friday, February 7th, 2025, with significant activity across a variety of sectors. ARK's largest transaction for the day involved ...

Cathie Wood's ARK ETFs have once again made notable adjustments to their portfolios, as revealed in their daily trade report for Tuesday, February 4th, 2025. The most significant move was the sale of ...

BTSG BrightSpring Health Services, Inc.

Parse Biosciences Inc. convinced an administrative tribunal to invalidate two 10x Genomics Inc. cell-analysis patents its products are accused of infringing. 10x sued Parse in August 2022 in the US ...

Challenged claims of 10X Genomics Inc.'s patent that discloses methods for analyzing nucleic acids from single cells are unpatentable as obvious over prior art, the Patent Trial and Appeal Board said, ...